Showing results (71-80 of 97) with videos related to
Sort By:
Pageof 10
Breast (Edinburgh, Scotland)|September 25, 2013
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trialHatem A Azim, Francoise Rothé, Claudia Monica Aura, et al.Nature Communications|November 26, 2024
Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implicationsXiaoxiao Wang, David Venet, Frédéric Lifrange, et al.Nature Communications|November 26, 2025
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 studyAndreas Papagiannis, Samira Majjaj, Francois P Duhoux, et al.JAMA Oncology|June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With ChemotherapyVeerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2019
Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III TrialFrançoise Rothé, Maria Joao Silva, David Venet, et al.Journal of the National Cancer Institute|June 8, 2018
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer PatientsMatteo Lambertini, Christine Campbell, José Bines, et al.European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumorsEleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.Nature Medicine|June 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER<sup>+</sup>HER2<sup>-</sup> breast cancer: a randomized phase 2 trialAlex De Caluwé, Isabelle Desmoulins, Kim Cao, et al.Plos One|August 31, 2013
Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancerOtto Metzger-Filho, Aurélie Catteau, Stefan Michiels, et al.The Journal of Clinical Investigation|June 20, 2013
CD4⁺ follicular helper T cell infiltration predicts breast cancer survivalChunyan Gu-Trantien, Sherene Loi, Soizic Garaud, et al.Pageof 10